Novel modified frailty index predicts completion of adjuvant chemotherapy in resectable pancreatic cancer in a dual center study
2025 · Scientific Reports · 4 citations
https://doi.org/10.1038/s41598-025-02365-5
S
Shozo Mori
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
25
Citations
4
h-index
0
i10-index
Shozo Mori is an academic researcher from Dokkyo Medical University. The author has contributed to research in topics: Colorectal Cancer Surgical Treatments & Pancreatic and Hepatic Oncology Research & Cancer-related Molecular Pathways. The author has an h-index of 4, co-authored 11 publications.
Papers by this author
worksN2 Lymph Node Metastasis Is a Useful Predictor of Recurrence in Patients With Stage III Rectal Cancer Undergoing Adjuvant Chemotherapy Using Tegafur–uracil/leucovorin
2023 · Anticancer Research · 1 citations
https://doi.org/10.21873/anticanres.16385
Clinical Impact of Cellular Senescence and RNA Dysregulation in HCC Is Associated With MASLD and HCV-SVR
2025 · Anticancer Research · 1 citations
https://doi.org/10.21873/anticanres.17452
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat